Maladies de la jonction neuromusculaire : Questions médicales fréquentes
Nom anglais: Neuromuscular Junction Diseases
Descriptor UI:D020511
Tree Number:C10.668.758
Termes MeSH sélectionnés :
Amyloid beta-Protein Precursor
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Maladies de la jonction neuromusculaire : Questions médicales les plus fréquentes",
"headline": "Maladies de la jonction neuromusculaire : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Maladies de la jonction neuromusculaire : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-06-27",
"dateModified": "2025-03-24",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Maladies de la jonction neuromusculaire"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Maladies neuromusculaires",
"url": "https://questionsmedicales.fr/mesh/D009468",
"about": {
"@type": "MedicalCondition",
"name": "Maladies neuromusculaires",
"code": {
"@type": "MedicalCode",
"code": "D009468",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C10.668"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Maladies de la jonction neuromusculaire",
"alternateName": "Neuromuscular Junction Diseases",
"code": {
"@type": "MedicalCode",
"code": "D020511",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Rizwan Qaisar",
"url": "https://questionsmedicales.fr/author/Rizwan%20Qaisar",
"affiliation": {
"@type": "Organization",
"name": "Basic Medical Sciences, College of Medicine, University of Sharjah, Sharjah, United Arab Emirates; Space Medicine Research Group, Sharjah Institute for Medical and Health Sciences, University of Sharjah, Sharjah 27272, United Arab Emirates; Cardiovascular Research Group, Sharjah Institute for Medical and Health Sciences, University of Sharjah, Sharjah 27272, United Arab Emirates. Electronic address: rqaisar@sharjah.ac.ae."
}
},
{
"@type": "Person",
"name": "Asima Karim",
"url": "https://questionsmedicales.fr/author/Asima%20Karim",
"affiliation": {
"@type": "Organization",
"name": "Basic Medical Sciences, College of Medicine, University of Sharjah, Sharjah, United Arab Emirates."
}
},
{
"@type": "Person",
"name": "David Lacomis",
"url": "https://questionsmedicales.fr/author/David%20Lacomis",
"affiliation": {
"@type": "Organization",
"name": "Departments of Neurology and Pathology (Neuropathology), University of Pittsburgh School of Medicine, Pittsburgh, PA; and."
}
},
{
"@type": "Person",
"name": "Ines Boehm",
"url": "https://questionsmedicales.fr/author/Ines%20Boehm",
"affiliation": {
"@type": "Organization",
"name": "Edinburgh Medical School: Biomedical Sciences, University of Edinburgh, Edinburgh, UK."
}
},
{
"@type": "Person",
"name": "Ross A Jones",
"url": "https://questionsmedicales.fr/author/Ross%20A%20Jones",
"affiliation": {
"@type": "Organization",
"name": "Edinburgh Medical School: Biomedical Sciences, University of Edinburgh, Edinburgh, UK."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Epidemiology of urinary tract infection in adults caused by extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae - a case-control study from Qatar.",
"datePublished": "2022-05-04",
"url": "https://questionsmedicales.fr/article/35755476",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.ijregi.2022.05.001"
}
},
{
"@type": "ScholarlyArticle",
"name": "A structurally informed human protein-protein interactome reveals proteome-wide perturbations caused by disease mutations.",
"datePublished": "2024-10-24",
"url": "https://questionsmedicales.fr/article/39448882",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41587-024-02428-4"
}
},
{
"@type": "ScholarlyArticle",
"name": "Quantitative Analysis of Protein-Protein Equilibrium Constants in Cellular Environments Using Single-Molecule Localization Microscopy.",
"datePublished": "2024-10-21",
"url": "https://questionsmedicales.fr/article/39432814",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1021/acs.nanolett.4c04394"
}
},
{
"@type": "ScholarlyArticle",
"name": "Early steps of protein disaggregation by Hsp70 chaperone and class B J-domain proteins are shaped by Hsp110.",
"datePublished": "2024-10-15",
"url": "https://questionsmedicales.fr/article/39404743",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.7554/eLife.94795"
}
},
{
"@type": "ScholarlyArticle",
"name": "Prone to loss: senescence-regulated protein degradation leads to lower protein extractability in aging tomato leaves.",
"datePublished": "2024-10-14",
"url": "https://questionsmedicales.fr/article/39414151",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.plantsci.2024.112284"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Maladies du système nerveux",
"item": "https://questionsmedicales.fr/mesh/D009422"
},
{
"@type": "ListItem",
"position": 3,
"name": "Maladies neuromusculaires",
"item": "https://questionsmedicales.fr/mesh/D009468"
},
{
"@type": "ListItem",
"position": 4,
"name": "Maladies de la jonction neuromusculaire",
"item": "https://questionsmedicales.fr/mesh/D020511"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Maladies de la jonction neuromusculaire - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Maladies de la jonction neuromusculaire",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-04-29",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Maladies de la jonction neuromusculaire",
"description": "Comment diagnostique-t-on une maladie de la jonction neuromusculaire ?\nQuels tests sont utilisés pour évaluer la force musculaire ?\nLes anticorps sont-ils importants dans le diagnostic ?\nQuelle imagerie est utilisée pour ces maladies ?\nLes tests génétiques sont-ils nécessaires ?",
"url": "https://questionsmedicales.fr/mesh/D020511?mesh_terms=Amyloid+beta-Protein+Precursor&page=1000#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Maladies de la jonction neuromusculaire",
"description": "Quels sont les symptômes courants de ces maladies ?\nLa fatigue musculaire est-elle un symptôme fréquent ?\nLes troubles de la vision peuvent-ils survenir ?\nLes symptômes varient-ils selon l'âge ?\nLes symptômes sont-ils constants ou fluctuants ?",
"url": "https://questionsmedicales.fr/mesh/D020511?mesh_terms=Amyloid+beta-Protein+Precursor&page=1000#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Maladies de la jonction neuromusculaire",
"description": "Peut-on prévenir les maladies de la jonction neuromusculaire ?\nLes vaccinations peuvent-elles aider ?\nUn mode de vie sain peut-il réduire les risques ?\nLes facteurs environnementaux jouent-ils un rôle ?\nLe stress peut-il aggraver les symptômes ?",
"url": "https://questionsmedicales.fr/mesh/D020511?mesh_terms=Amyloid+beta-Protein+Precursor&page=1000#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Maladies de la jonction neuromusculaire",
"description": "Quels traitements sont disponibles pour ces maladies ?\nLa plasmaphérèse est-elle utilisée ?\nLes corticostéroïdes sont-ils efficaces ?\nLa rééducation est-elle importante ?\nY a-t-il des traitements expérimentaux ?",
"url": "https://questionsmedicales.fr/mesh/D020511?mesh_terms=Amyloid+beta-Protein+Precursor&page=1000#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Maladies de la jonction neuromusculaire",
"description": "Quelles sont les complications possibles ?\nLes complications peuvent-elles être graves ?\nComment les complications sont-elles gérées ?\nLes complications affectent-elles la qualité de vie ?\nLes complications peuvent-elles survenir rapidement ?",
"url": "https://questionsmedicales.fr/mesh/D020511?mesh_terms=Amyloid+beta-Protein+Precursor&page=1000#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Maladies de la jonction neuromusculaire",
"description": "Quels sont les facteurs de risque connus ?\nLe sexe influence-t-il le risque ?\nLes infections peuvent-elles déclencher ces maladies ?\nLe tabagisme est-il un facteur de risque ?\nL'exposition à des toxines est-elle préoccupante ?",
"url": "https://questionsmedicales.fr/mesh/D020511?mesh_terms=Amyloid+beta-Protein+Precursor&page=1000#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostique-t-on une maladie de la jonction neuromusculaire ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des tests électromyographiques et des analyses sanguines."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer la force musculaire ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests de force manuelle et des évaluations fonctionnelles sont réalisés."
}
},
{
"@type": "Question",
"name": "Les anticorps sont-ils importants dans le diagnostic ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la détection d'anticorps spécifiques aide à confirmer certaines maladies."
}
},
{
"@type": "Question",
"name": "Quelle imagerie est utilisée pour ces maladies ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'IRM peut être utilisée pour évaluer les muscles et détecter des anomalies."
}
},
{
"@type": "Question",
"name": "Les tests génétiques sont-ils nécessaires ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils peuvent être utiles pour identifier des formes héréditaires de la maladie."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants de ces maladies ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent faiblesse musculaire, fatigue et difficultés à avaler."
}
},
{
"@type": "Question",
"name": "La fatigue musculaire est-elle un symptôme fréquent ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la fatigue s'aggrave souvent avec l'activité physique prolongée."
}
},
{
"@type": "Question",
"name": "Les troubles de la vision peuvent-ils survenir ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des problèmes oculaires comme la ptose peuvent se manifester."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon l'âge ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'âge d'apparition et la gravité des symptômes peuvent varier."
}
},
{
"@type": "Question",
"name": "Les symptômes sont-ils constants ou fluctuants ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils peuvent fluctuer, s'aggravant après des efforts ou en fin de journée."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les maladies de la jonction neuromusculaire ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de prévention spécifique, mais un suivi médical régulier est conseillé."
}
},
{
"@type": "Question",
"name": "Les vaccinations peuvent-elles aider ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les vaccinations ne préviennent pas ces maladies, mais protègent contre d'autres infections."
}
},
{
"@type": "Question",
"name": "Un mode de vie sain peut-il réduire les risques ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un mode de vie sain peut améliorer la santé générale, mais ne prévient pas ces maladies."
}
},
{
"@type": "Question",
"name": "Les facteurs environnementaux jouent-ils un rôle ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certains facteurs environnementaux peuvent influencer le développement de ces maladies."
}
},
{
"@type": "Question",
"name": "Le stress peut-il aggraver les symptômes ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress peut exacerber les symptômes et affecter la qualité de vie."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour ces maladies ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent des médicaments immunosuppresseurs et des thérapies physiques."
}
},
{
"@type": "Question",
"name": "La plasmaphérèse est-elle utilisée ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut aider à réduire les symptômes en éliminant les anticorps nocifs."
}
},
{
"@type": "Question",
"name": "Les corticostéroïdes sont-ils efficaces ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent améliorer la force musculaire et réduire l'inflammation."
}
},
{
"@type": "Question",
"name": "La rééducation est-elle importante ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la rééducation physique aide à maintenir la force et la fonction musculaire."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements expérimentaux ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des thérapies géniques et des traitements ciblés sont en cours d'évaluation."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des difficultés respiratoires et des infections pulmonaires."
}
},
{
"@type": "Question",
"name": "Les complications peuvent-elles être graves ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines complications peuvent mettre en danger la vie, nécessitant une attention urgente."
}
},
{
"@type": "Question",
"name": "Comment les complications sont-elles gérées ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles sont gérées par des soins médicaux appropriés et un suivi régulier."
}
},
{
"@type": "Question",
"name": "Les complications affectent-elles la qualité de vie ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent réduire la qualité de vie et nécessiter des adaptations."
}
},
{
"@type": "Question",
"name": "Les complications peuvent-elles survenir rapidement ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent se développer rapidement, nécessitant une surveillance étroite."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque connus ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent des antécédents familiaux, des maladies auto-immunes et l'âge."
}
},
{
"@type": "Question",
"name": "Le sexe influence-t-il le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines maladies de la jonction neuromusculaire sont plus fréquentes chez les femmes."
}
},
{
"@type": "Question",
"name": "Les infections peuvent-elles déclencher ces maladies ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines infections virales peuvent précipiter l'apparition de ces maladies."
}
},
{
"@type": "Question",
"name": "Le tabagisme est-il un facteur de risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme peut augmenter le risque de développer des maladies neuromusculaires."
}
},
{
"@type": "Question",
"name": "L'exposition à des toxines est-elle préoccupante ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exposition à certaines toxines environnementales peut être un facteur de risque."
}
}
]
}
]
}
Community-acquired urinary tract infection (UTI) is the most common infection caused by extended-spectrum beta-lactamase (ESBL)-producing organisms....
to estimate the prevalence of ESBL-UTI in adults and to identify potential risk factors that may predispose to ESBL-UTI....
A retrospective study involving adult patients with UTI caused by ESBL-producing organisms was undertaken. Patients with UTI caused by non-ESBL-producing organisms represented the control group....
In total, 1100 UTI isolates were included in the study, 277 of which were ESBL positive. The prevalence rate was 25.2%. The mean age of patients was 55.87 years. On univariate analysis, prior history ...
In Qatar, the prevalence of ESBL-UTI in adults is modest. Recent exposure to antibiotics, previous ESBL-UTI and invasive urological procedures were found to be independent risk factors for ESBL-UTI....
To assist the translation of genetic findings to disease pathobiology and therapeutics discovery, we present an ensemble deep learning framework, termed PIONEER (Protein-protein InteractiOn iNtErfacE ...
Current methods for determining equilibrium constants often operate in three-dimensional environments, which may not accurately reflect interactions with membrane-bound proteins. With our technique, b...
Hsp70 is a key cellular system counteracting protein misfolding and aggregation, associated with stress, ageing, and disease. Hsp70 solubilises aggregates and aids protein refolding through substrate ...
The utilization of proteins extracted from tomato (Solanum lycopersicum) leaves as cost-effective resources for human consumption or animal feed has gained interest. Thus, increasing protein extractab...
The effect of ultrasound-assisted protein-glutaminase (PG) deamidation on the physicochemical properties of rice protein (RP) was investigated. After ultrasound pretreatment, the degree of deamidation...
Despite the numerous health benefits and high digestibility of hemp seed protein isolate (HPI), its low solubility at neutral pH limits its utilization in the food industry. Therefore, we subjected in...
The recruitment of the protein spleen tyrosine kinase (Syk) to membrane-bound immune receptors is an essential step in initiating an immune response mediated through the activated receptors. Syk recog...
The mechanisms behind Mycoprotein (MYC) formation, especially the interactions with egg white proteins (EWP), are not fully understood despite the widespread use of fungal proteins. This study investi...
α-N-Methylation (Nα-methylation), catalyzed by protein N-terminal methyltransferases (NTMTs), constitutes a crucial post-translational modification involving the transfer of a methyl group from...